Drugs / perfluorinated gas/oxygen mixture
perfluorinated gas/oxygen mixture
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02019251 | Dec 2013 → Jun 2014 | — | Hal C Charles | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | perfluorinated gas/oxygen mixture | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02019251 ↗ |
| Modality | Diagnostic / imaging agent | “as an MRI contrast agent” NCT02019251 ↗ |
| Route | Inhaled | “as inhaled inert contrast agents” NCT02019251 ↗ |